Covered recipient · General Payments record
KARIN C LI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$1,137.98
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $653.76 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $216.66 | 7 |
| ABBVIE INC. | $135.41 | 2 |
| Acerta Pharma LLC | $121.82 | 1 |
| Curonix LLC | $105.86 | 1 |
| Phadia US Inc. | $23.82 | 1 |
| GlaxoSmithKline, LLC. | $18.96 | 1 |
| Amgen Inc. | $16.50 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $14.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.44 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104172326 | CMS |
| ABBVIE INC. | $124.97 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104172328 | CMS |
| Amgen Inc. | $16.50 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117310553 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.82 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105882679 | CMS |
| Boston Scientific Corporation | $14.73 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092706758 | CMS |
| Curonix LLC | $105.86 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132909495 | CMS |
| GlaxoSmithKline, LLC. | $18.96 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116386738 | CMS |
| Lilly USA, LLC | $22.67 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135076323 | CMS |
| Lilly USA, LLC | $102.10 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135095920 | CMS |
| Lilly USA, LLC | $17.04 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135076319 | CMS |
| Lilly USA, LLC | $20.55 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135120667 | CMS |
| Lilly USA, LLC | $16.93 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135120665 | CMS |
| Lilly USA, LLC | $20.64 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135097872 | CMS |
| Lilly USA, LLC | $16.73 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135076321 | CMS |
| Phadia US Inc. | $23.82 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067581174 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.